Genomictree Inc. (228760.KQ)
KRW 23550.0
(3.06%)
KRW 23550.0
(3.06%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.75 Billion KRW | -32.05% |
| 2022 | -6.63 Billion KRW | 41.96% |
| 2021 | -11.42 Billion KRW | 3.14% |
| 2020 | -11.79 Billion KRW | -15.7% |
| 2019 | -10.19 Billion KRW | -310.34% |
| 2018 | -2.48 Billion KRW | -17.58% |
| 2017 | -2.11 Billion KRW | -2.53% |
| 2016 | -2.06 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.65 Billion KRW | -89.19% |
| 2024 Q2 | -2.81 Billion KRW | -6.03% |
| 2023 Q1 | -3.16 Billion KRW | 37.72% |
| 2023 Q4 | -1.4 Billion KRW | 48.06% |
| 2023 FY | -8.75 Billion KRW | -32.05% |
| 2023 Q2 | -1.87 Billion KRW | 40.71% |
| 2023 Q3 | -2.69 Billion KRW | -43.75% |
| 2022 Q2 | -9.72 Billion KRW | -181.13% |
| 2022 FY | -6.63 Billion KRW | 41.96% |
| 2022 Q4 | -5.08 Billion KRW | -33.47% |
| 2022 Q3 | -3.8 Billion KRW | 60.83% |
| 2022 Q1 | 11.98 Billion KRW | 503.41% |
| 2021 FY | -11.42 Billion KRW | 3.14% |
| 2021 Q3 | -4.85 Billion KRW | 0.0% |
| 2021 Q4 | -2.97 Billion KRW | 38.74% |
| 2020 FY | -11.79 Billion KRW | -15.7% |
| 2019 FY | -10.19 Billion KRW | -310.34% |
| 2018 FY | -2.48 Billion KRW | -17.58% |
| 2017 FY | -2.11 Billion KRW | -2.53% |
| 2016 FY | -2.06 Billion KRW | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| HLB Co., Ltd. | -189.07 Billion KRW | 95.369% |
| iNtRON Biotechnology, Inc. | -9.69 Billion KRW | 9.689% |
| BINEX Co., Ltd. | 4.67 Billion KRW | 287.465% |
| Bioneer Corporation | -10.58 Billion KRW | 17.295% |
| Anterogen.Co.,Ltd. | -2.84 Billion KRW | -208.219% |
| MEDIPOST Co., Ltd. | 5.83 Billion KRW | 249.932% |
| CrystalGenomics, Inc. | -48.92 Billion KRW | 82.103% |
| Helixmith Co., Ltd | -64.08 Billion KRW | 86.338% |
| Chabiotech Co.,Ltd. | -8.43 Billion KRW | -3.852% |
| Medy-Tox Inc. | 9.75 Billion KRW | 189.759% |
| Peptron, Inc. | -15.92 Billion KRW | 45.006% |
| Amicogen, Inc. | -23.28 Billion KRW | 62.403% |
| Genexine, Inc. | -66.87 Billion KRW | 86.907% |
| HLB Therapeutics Co.,Ltd. | -2.3 Billion KRW | -280.34% |
| LegoChem Biosciences, Inc. | -73.7 Billion KRW | 88.12% |
| ALTEOGEN Inc. | -3.37 Billion KRW | -159.687% |
| PharmaResearch Co., Ltd. | 76.55 Billion KRW | 111.438% |
| SillaJen, Inc. | -20.36 Billion KRW | 57.013% |
| JETEMA, Co., Ltd. | 13.96 Billion KRW | 162.696% |
| OliX Pharmaceuticals,Inc | -19.1 Billion KRW | 54.161% |
| MedPacto, Inc. | -35.32 Billion KRW | 75.213% |
| D&D Pharmatech | 3.93 Billion KRW | 322.584% |
| EASY BIO,Inc. | 15.54 Billion KRW | 156.331% |
| GI Innovation, Inc. | -55.49 Billion KRW | 84.222% |